ArticleFrontiers in oncology2021

Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy.

Yoshiyuki Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.